Market Tracker

07/25 9:59am ET

Zimmer Biomet Holdings Inc (NYSE:ZBH)

124.07
Delayed Data
As of 9:44am ET
 -0.41 / -0.33%
Today’s Change
88.27
Today|||52-Week Range
127.16
+20.94%
Year-to-Date
Johnson & Johnson Reports 4% Sales Growth for the Second Quarter
Jul 22 / GuruFocus News - Paid Partner Content
Zimmer Biomet (ZBH) Q2 Earnings: A Beat in the Cards?
Jul 21 / Zacks.com - Paid Partner Content
Nutrisystem (NTRI) Q2 Earnings: What's in the Cards?
Jul 22 / Zacks.com - Paid Partner Content
Baxter International (BAX) Q2 Earnings: What's in Store?
Jul 21 / Zacks.com - Paid Partner Content
Stryker (SYK) Tops Q2 Earnings, Stock Down on Dull Q3 View
Jul 22 / Zacks.com - Paid Partner Content
5 Big Medtech Stocks Investors Love Right Now -- but Should You Buy Them?
Jul 19 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close124.48
Today’s open124.48
Day’s range123.98 - 124.48
Volume41,802
Average volume (3 months)1,504,940
Market cap$24.9B
Dividend yield0.77%
Data as of 9:44am ET, 07/25/2016

Growth & Valuation

Earnings growth (last year)-81.62%
Earnings growth (this year)+15.34%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+28.34%
P/E ratio413.6
Price/Sales3.25
Price/Book2.55

Competitors

 Today’s
change
Today’s
% change
EWEdwards Lifesciences...-0.25-0.24%
BSXBoston Scientific Co...-0.15-0.64%
BCRC R Bard Inc-0.98-0.43%
BDXBecton Dickinson and...-0.74-0.43%
Data as of 9:59am ET, 07/25/2016

Financials

Last reporting dateJuly 21, 2016
EPS forecast (this quarter)$1.97
Annual revenue (last year)$6.0B
Annual profit (last year)$147.0M
Net profit margin2.45%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
David C. Dvorak
Senior VP-Global Operations &
Logistics
Robin T. Barney
Corporate headquarters
Warsaw, Indiana

Forecasts